Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Decreases By 82.5%

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a large drop in short interest during the month of April. As of April 30th, there was short interest totaling 8,769 shares, a drop of 82.5% from the April 15th total of 50,051 shares. Based on an average daily trading volume, of 410,091 shares, the short-interest ratio is currently 0.0 days.

Siemens Healthineers Price Performance

Siemens Healthineers stock traded up $0.01 during trading on Thursday, reaching $19.89. The company had a trading volume of 52,886 shares, compared to its average volume of 169,445. The firm’s 50-day simple moving average is $21.51 and its 200 day simple moving average is $24.17. Siemens Healthineers has a 52 week low of $19.54 and a 52 week high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. The business had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

Analyst Ratings Changes

Separately, Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research note on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.